Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease

By Klivenyi Peter   Gardian Gabrielle   Calingasan Noel   Yang Lichuan   Beal M.  

Journal of Molecular Neuroscience, Vol. 21, Iss. 3, 2003-10 ,pp. : 191-198

Humana Press, Inc

Access to resources Recommend Favorite

Neuroprotective effects of the novel D 3 /D 2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole

By Joyce J.N.   Presgraves S.   Renish L.   Borwege S.   Osredkar T.   Hagner D.   Replogle M.   PazSoldan M.   Millan M.J.  

Experimental Neurology, Vol. 184, Iss. 1, 2003-11 ,pp. : 393-407

Elsevier

Access to resources Recommend Favorite

On CNV components: Multivariate analysis of single trial ERPs by S1-, S1-S2 and S1-S2+R paradigm

By Yamamoto T.   Saito Y.   Sugihara K.  

Electroencephalography and Clinical Neurophysiology, Vol. 103, Iss. 1, 1997-07 ,pp. : 73-74

Elsevier

Access to resources Recommend Favorite

Antioxidant Effect of Gold Nanoparticles Synthesised from Curcuma Longa Restrains 1-Methyl-2-Phenyl Pyridinium Ion Induced Stress in PC12 Cells

By Nellore Jayshree   Pauline Cynthia   Amarnath Kanchana   Shilpa P.N.  

Journal of Nanoneuroscience, Vol. 2, Iss. 1, 2012-04 ,pp. : 63-74

American Scientific Publishers

Access to resources Recommend Favorite

Stage-Specific Modulation of Cortical Neuronal Development by Mmu-miR-134

By Gaughwin Philip   Ciesla Maciej   Yang Henry   Lim Bing   Brundin Patrik  

Cerebral Cortex, Vol. 21, Iss. 8, 2011-08 ,pp. : 1857-1869

Oxford University Press

Access to resources Recommend Favorite